liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Rapid Implementation of Telegenetic Counseling in the COVID-19 and Swedish Healthcare Context: A Feasibility Study
Linköping University, Department of Health, Medicine and Caring Sciences, Division of Society and Health. Linköping University, Faculty of Medicine and Health Sciences. Region Östergötland, Center for Diagnostics, Clinical genetics.ORCID iD: 0000-0001-7192-4532
Linköping University, Department of Health, Medicine and Caring Sciences, Division of Nursing Sciences and Reproductive Health. Linköping University, Faculty of Medicine and Health Sciences. Region Östergötland, Local Health Care Services in East Östergötland, Department of Internal Medicine in Norrköping.ORCID iD: 0000-0001-7431-2873
Linköping University, Department of Behavioural Sciences and Learning, Disability Research Division. Linköping University, Faculty of Arts and Sciences. Linköping University, The Swedish Institute for Disability Research.ORCID iD: 0000-0002-0446-0827
Department of Rehabilitation, School of Health and Welfare, Jönköping University, Jönköping, Sweden.
Show others and affiliations
2022 (English)In: Frontiers in Health Services, E-ISSN 2813-0146, Vol. 2Article in journal (Refereed) Published
Abstract [sv]

This study reports the process and preliminary findings of rapid implementation oftelegenetic counseling in the context of Swedish healthcare and COVID-19 pandemic,from both a patient and a provider perspective. Fourty-nine patients and 6 healthcareprofessionals were included in this feasibility study of telegenetic counseling in aregional Department of Clinical Genetics in Sweden. Telegenetic counseling is heredefined as providing genetic counseling to patients by video (n =30) or telephone (n= 19) appointments. Four specific feasibility aspects were considered: acceptability,demand, implementation, and preliminary efficacy. Several measures were used includingthe Genetic Counseling Outcome Scale 24 (collected pre- and post-counseling); theTelehealth Usability Questionnaire; a short study specific evaluation and Visiba Careevaluations, all collected post-counseling. The measures were analyzed with descriptivestatistics and the preliminary results show a high level of acceptance and demand, fromboth patients and providers. Results also indicate successful initial implementation in theregional Department of Clinical Genetics and preliminary efficacy, as shown by significantclinically important improvement in patients’ empowerment levels.

Place, publisher, year, edition, pages
Frontiers Media S.A., 2022. Vol. 2
National Category
Social and Clinical Pharmacy
Identifiers
URN: urn:nbn:se:liu:diva-189246DOI: 10.3389/frhs.2022.848512ISI: 001112626500001OAI: oai:DiVA.org:liu-189246DiVA, id: diva2:1703756
Available from: 2022-10-14 Created: 2022-10-14 Last updated: 2024-05-16Bibliographically approved
In thesis
1. Improving Access and Quality of Genetic Counselling in Clinical Care in Sweden: The Value of eHealth Solutions and a Validated Outcome Measure
Open this publication in new window or tab >>Improving Access and Quality of Genetic Counselling in Clinical Care in Sweden: The Value of eHealth Solutions and a Validated Outcome Measure
2023 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Genetic counselling is increasingly important for investigations into hereditary diseases in the field of clinical genetics. The increase in demand is due to the discovery of more genetically caused diseases, increased complexity and awareness of genetic testing. However, access to genetic counselling is limited worldwide, as in Sweden, and not always offered as needed, because there is a lack of trained professionals, such as genetic counsellors and geneticists. Additionally, genetic counselling is difficult to evaluate as there is no validated quality measure for genetic counselling in Swedish. This work investigates important factors for improving access to and quality of genetic counselling in Sweden.

The studied factors include such as the genetic counsellors, the use and implementation of eHealth technology, and the possibility to evaluate these areas using a valid outcome measure in Swedish. This dissertation consists of four studies. The first is a questionnaire study that found that genetic counsellors in Sweden play an integral role in patient care and access, and provide quality patient support throughout the clinical encounter. However, it also found that there was a lack of trained genetic counsellors and that they were overly burdened with administrative work, such as sample handling, billing and making appointments. This reduced the genetic counsellors’ time spent directly with patients, thus hampering patient access. The second study investigated healthcare professionals’ pre-pandemic perceptions of using a specific eHealth technology providing genetic counselling via video or telephone, termed telegenetic counselling (TGC) throughout this dissertation. Findings showed that TGC was considered appropriate, believed to increase patient access and autonomy, and improve patient care. Yet, the healthcare professionals expressed some reluctance and identified many barriers to using TGC, such as the lack of evidence, and anticipated issues with technology and resources. Nevertheless, taking place during the COVID-19 pandemic, the third study investigated the feasibility of rapid implementation of TGC in a real, clinical context. Both healthcare professionals and patients found TGC acceptable, useful and satisfactory, and TGC also improved access to genetic counselling during the pandemic. The implementation of TGC proved effective in regards to the overall goal of genetic counselling: increased patient empowerment after genetic counselling. This was measured by the newly adapted patient-reported outcome measure in genetic counselling in Swedish, the GCOS-24swe. The fourth study performed a psychometric evaluation of the GCOS-24swe and showed validity, reliability, and responsiveness of the outcome measure. Therefore, the GCOS-24swe provides a useful clinical quality measure to inform developments in genetic counselling practice, individualised patient care, and evaluation of implementation efforts in Sweden. Finally, a synthesis of these research findings results in a suggested implementation strategy for TGC in the clinical context. In summary, this dissertation identifies ways to improve the access to and measure the quality of genetic counselling in Sweden.

Abstract [sv]

Klinisk genetik utreder personer för olika ärftliga sjukdomar. Genetisk vägledning är en viktig del i denna process. Genetisk vägledning innebär information och stöd till personer under utredning, för att hjälpa dem förstå och fatta beslut om olika saker, t.ex. genetisk testning. Genetisk vägledning sker främst genom samtal som ska vara anpassade till personens behov och målet är att stärka personen i sin egen situation.

Efterfrågan på genetisk vägledning är högre än tillgången, och det råder brist på utbildade genetiska vägledare i Sverige. Ett alternativ för att nå fler personer i behov av genetisk vägledning kan vara att erbjuda samtalen med hjälp av eHälsa. Besöken genomförs digitalt på distans via video eller telefon. Behovet av detta blev särskilt påtagligt under COVID-19-pandemin. Sveriges befolkning är vana vid internet och använder redan många tekniska lösningar i vardagen. Men forskning har tidigare visat att det är svårt att införa nya lösningar i sjukvården, inklusive genetisk vägledning på distans. Det är också viktigt att kunna mäta kvaliteten på vården, inklusive genetisk vägledning, för att veta om effekterna är bra. Det är dock svårt eftersom det saknas mått för detta på svenska. Den här forskningen undersökte därför hur tillgång och kvalitet på genetisk vägledning i Sverige kunde förbättras. Det gjordes bl.a. genom att studera de genetiska vägledarna, användning och införandet av eHälsa i Sverige, och utveckla en enkät på svenska för utvärdering av genetisk vägledning.

I den första studien fann vi att genetiska vägledare i Sverige ökade tillgängligheten för patienter. Men detta kunde bli ännu bättre, då de genetiska vägledarna var överbelastade med administrativa uppgifter och önskade mer tid för patientkontakt. I den andra studien intervjuades vårdpersonal, som visade sig vara både positiva och tveksamma till att använda distansbesök istället för att ses fysiskt. Vårdpersonalen önskade först att det fanns bevis och resurser på plats för att distansbesöken skulle fungera. Sedan kom COVID, och distansbesök infördes snabbt på kliniken. Utvärderingen visade gott resultat för distansbesöken under COVID-pandemin. Deltagande patienter och vårdgivare upplevde att besöken på distans behövdes och att de var nöjda med dem. Samtidigt togs en enkät fram på svenska för att mäta effekterna av den genetiska vägledningen hos patienter. Den kallas GCOS-24swe, och har visat god kvalitet. Utvärderingar med GCOS-24swe har visat på god effekt av distansbesöken för genetisk vägledning. Sammanfattningsvis visade resultaten från studierna att det går att förbättra tillgången till och säkerställa kvaliteten på genetisk vägledning i Sverige.

Place, publisher, year, edition, pages
Linköping: Linköping University Electronic Press, 2023. p. 97
Series
Linköping University Medical Dissertations, ISSN 0345-0082 ; 1834
Keywords
Genetic counselling, Empowerment, Outcome measures, eHealth, Implementation
National Category
Health Care Service and Management, Health Policy and Services and Health Economy
Identifiers
urn:nbn:se:liu:diva-193290 (URN)10.3384/9789179295943 (DOI)9789179295936 (ISBN)9789179295943 (ISBN)
Public defence
2023-06-01, Berzeliussalen, Building 463, Campus US, Linköping, 13:00
Opponent
Supervisors
Note

Funding agencies: Region Östergötland (Strategy area: Healthcare and welfare, Centre for Diagnostics, Department of Clinical Genetics, Centre for Rare Diseases, Southeast), FORSS, Linköping University (Faculty of Medicine and Health Sciences, Department of Health, Medicine and Caring Sciences)

Available from: 2023-04-28 Created: 2023-04-28 Last updated: 2023-05-05Bibliographically approved

Open Access in DiVA

fulltext(786 kB)162 downloads
File information
File name FULLTEXT01.pdfFile size 786 kBChecksum SHA-512
4d60421cc240fa9db11b301ccb9b3beedf06e65e80e48738a29ca9c459af3a3bff61d4a21e18aecb5d68facab11dddfd94a5802cca6d71dd13731894461e7801
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Authority records

Pestoff, RebeckaJohansson, PeterDanielsson, HenrikGunnarsson, Cecilia

Search in DiVA

By author/editor
Pestoff, RebeckaJohansson, PeterDanielsson, HenrikGunnarsson, Cecilia
By organisation
Division of Society and HealthFaculty of Medicine and Health SciencesClinical geneticsDivision of Nursing Sciences and Reproductive HealthDepartment of Internal Medicine in NorrköpingDisability Research DivisionFaculty of Arts and SciencesThe Swedish Institute for Disability ResearchDepartment of Biomedical and Clinical SciencesÖvr Regionledningskontoret
Social and Clinical Pharmacy

Search outside of DiVA

GoogleGoogle Scholar
Total: 162 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 337 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf